Özet:

The aim of the study is to provide a comprehensive assessment of “patient perspectives and social aspects” dimension of Health Technology Assessment Method for DMARDs, used in treatment of Rheumatoid Arthritis (RA) in Turkey. Delphi panel technique and interviews with representatives of patients’ associations were used to collect data. As a result of the study, it was observed that there was no difference between individuals within the scope of social security institutions in terms of access to DMARDs, but there were regional differences regarding access to rheumatologists due to their low number. The study also found that patients did not face any significant social or economic barriers to accessing DMARDs, but their knowledge of RA was both insufficient and unequal among patients. A full understanding of the benefit and safety of treatment by patients; Adherence to treatment is important for achieving the planned goal and the success of policies created for RA management. Therefore, at all levels of disease management, it would be beneficial to consider joint decision-making by the patient / caregiver-physician, the use of informed consent forms and the vital role of health professionals.

Anahtar Kelimeler: